These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 18431484)

  • 21. Intratumoral immunotherapy with TLR7/8 agonist MEDI9197 modulates the tumor microenvironment leading to enhanced activity when combined with other immunotherapies.
    Mullins SR; Vasilakos JP; Deschler K; Grigsby I; Gillis P; John J; Elder MJ; Swales J; Timosenko E; Cooper Z; Dovedi SJ; Leishman AJ; Luheshi N; Elvecrog J; Tilahun A; Goodwin R; Herbst R; Tomai MA; Wilkinson RW
    J Immunother Cancer; 2019 Sep; 7(1):244. PubMed ID: 31511088
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Innate Immune Activity Correlates with CD4 T Cell-Associated HIV-1 DNA Decline during Latency-Reversing Treatment with Panobinostat.
    Olesen R; Vigano S; Rasmussen TA; Søgaard OS; Ouyang Z; Buzon M; Bashirova A; Carrington M; Palmer S; Brinkmann CR; Yu XG; Østergaard L; Tolstrup M; Lichterfeld M
    J Virol; 2015 Oct; 89(20):10176-89. PubMed ID: 26223643
    [TBL] [Abstract][Full Text] [Related]  

  • 23. TLR8 activates HIV from latently infected cells of myeloid-monocytic origin directly via the MAPK pathway and from latently infected CD4+ T cells indirectly via TNF-α.
    Schlaepfer E; Speck RF
    J Immunol; 2011 Apr; 186(7):4314-24. PubMed ID: 21357269
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Toll-like receptor agonists influence the magnitude and quality of memory T cell responses after prime-boost immunization in nonhuman primates.
    Wille-Reece U; Flynn BJ; Loré K; Koup RA; Miles AP; Saul A; Kedl RM; Mattapallil JJ; Weiss WR; Roederer M; Seder RA
    J Exp Med; 2006 May; 203(5):1249-58. PubMed ID: 16636134
    [TBL] [Abstract][Full Text] [Related]  

  • 25. TLR8 combined withTLR3 or TLR4 agonists enhances DC-NK driven effector Tc1 cells.
    Nouri-Shirazi M; Tamjidi S; Nourishirazi E; Guinet E
    Immunol Lett; 2018 Jan; 193():58-66. PubMed ID: 29103998
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Stabilized immune modulatory RNA compounds as agonists of Toll-like receptors 7 and 8.
    Lan T; Kandimalla ER; Yu D; Bhagat L; Li Y; Wang D; Zhu F; Tang JX; Putta MR; Cong Y; Trombino AF; Sullivan T; Agrawal S
    Proc Natl Acad Sci U S A; 2007 Aug; 104(34):13750-5. PubMed ID: 17698957
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Human TLR8 Senses RNA From
    Coch C; Hommertgen B; Zillinger T; Daßler-Plenker J; Putschli B; Nastaly M; Kümmerer BM; Scheunemann JF; Schumak B; Specht S; Schlee M; Barchet W; Hoerauf A; Bartok E; Hartmann G
    Front Immunol; 2019; 10():371. PubMed ID: 30972055
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Novel TLR 7/8 agonists for improving NK cell mediated antibody-dependent cellular cytotoxicity (ADCC).
    Khanna V; Kim H; Zhang W; Larson P; Shah M; Griffith TS; Ferguson D; Panyam J
    Sci Rep; 2021 Feb; 11(1):3346. PubMed ID: 33558639
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Synthetic TLR agonists reveal functional differences between human TLR7 and TLR8.
    Gorden KB; Gorski KS; Gibson SJ; Kedl RM; Kieper WC; Qiu X; Tomai MA; Alkan SS; Vasilakos JP
    J Immunol; 2005 Feb; 174(3):1259-68. PubMed ID: 15661881
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Characterization of conserved viral leader RNA sequences that stimulate innate immunity through TLRs.
    Forsbach A; Nemorin JG; Völp K; Samulowitz U; Montino C; Müller C; Tluk S; Hamm S; Bauer S; Lipford GB; Vollmer J
    Oligonucleotides; 2007; 17(4):405-17. PubMed ID: 18072859
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Distinct indirect pathways govern human NK-cell activation by TLR-7 and TLR-8 agonists.
    Gorski KS; Waller EL; Bjornton-Severson J; Hanten JA; Riter CL; Kieper WC; Gorden KB; Miller JS; Vasilakos JP; Tomai MA; Alkan SS
    Int Immunol; 2006 Jul; 18(7):1115-26. PubMed ID: 16728430
    [TBL] [Abstract][Full Text] [Related]  

  • 32. TLR8-driven IL-12-dependent reciprocal and synergistic activation of NK cells and monocytes by immunostimulatory RNA.
    Berger M; Ablasser A; Kim S; Bekeredjian-Ding I; Giese T; Endres S; Hornung V; Hartmann G
    J Immunother; 2009 Apr; 32(3):262-71. PubMed ID: 19242374
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Human dendritic cells stimulated via TLR7 and/or TLR8 induce the sequential production of Il-10, IFN-gamma, and IL-17A by naive CD4+ T cells.
    Lombardi V; Van Overtvelt L; Horiot S; Moingeon P
    J Immunol; 2009 Mar; 182(6):3372-9. PubMed ID: 19265114
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immunization with HIV-1 Gag protein conjugated to a TLR7/8 agonist results in the generation of HIV-1 Gag-specific Th1 and CD8+ T cell responses.
    Wille-Reece U; Wu CY; Flynn BJ; Kedl RM; Seder RA
    J Immunol; 2005 Jun; 174(12):7676-83. PubMed ID: 15944268
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Oligodeoxynucleotides differentially modulate activation of TLR7 and TLR8 by imidazoquinolines.
    Gorden KK; Qiu X; Battiste JJ; Wightman PP; Vasilakos JP; Alkan SS
    J Immunol; 2006 Dec; 177(11):8164-70. PubMed ID: 17114492
    [TBL] [Abstract][Full Text] [Related]  

  • 36. TLR7/8 agonist induces a post-entry SAMHD1-independent block to HIV-1 infection of monocytes.
    Hofmann H; Vanwalscappel B; Bloch N; Landau NR
    Retrovirology; 2016 Dec; 13(1):83. PubMed ID: 27905985
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Toll-like receptor-2/7-mediated T cell activation: An innate potential to augment CD8
    Freen-van Heeren JJ
    Scand J Immunol; 2021 May; 93(5):e13019. PubMed ID: 33377182
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Differences in TLR7/8 activation between monocytes and macrophages.
    Eng HL; Hsu YY; Lin TM
    Biochem Biophys Res Commun; 2018 Feb; 497(1):319-325. PubMed ID: 29448098
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Activation of myeloid dendritic cells, effector cells and regulatory T cells in lichen planus.
    Domingues R; de Carvalho GC; Aoki V; da Silva Duarte AJ; Sato MN
    J Transl Med; 2016 Jun; 14(1):171. PubMed ID: 27286889
    [TBL] [Abstract][Full Text] [Related]  

  • 40. TLR7/8 Agonist-Loaded Nanoparticles Augment NK Cell-Mediated Antibody-Based Cancer Immunotherapy.
    Kim H; Khanna V; Kucaba TA; Zhang W; Sehgal D; Ferguson DM; Griffith TS; Panyam J
    Mol Pharm; 2020 Jun; 17(6):2109-2124. PubMed ID: 32383885
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.